申请人:Asahi Kasei Pharma Corporation
公开号:EP1403269A1
公开(公告)日:2004-03-31
A pyridine ring-containing benzoxazinone derivative or a pharmaceutically acceptable salt or tautomer thereof represented by general formula (1):
(wherein R1 to R6 and n are as defined in the description) has excellent inhibitory activity against a protease. Thus, the benzoxazinone derivative or a pharmaceutically acceptable salt thereof is useful as an active ingredient for a therapeutic agent for virus infections, particularly herpes virus infections.
一种含有吡啶环的苯并噁唑酮衍生物或其药用可接受的盐或互变异构体,由通式(1)表示:(其中R1至R6和n如描述中定义)对蛋白酶具有出色的抑制活性。因此,该苯并噁唑酮衍生物或其药用可接受的盐可作为抗病毒治疗剂的活性成分,特别是对疱疹病毒感染。